Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.

Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.

Bibliografski detalji
Glavni autori:	Luqmani, R, Jayne, D, Gaskin, G, EUVAS
Format:	Conference item
Izdano:	2002

Slični predmeti

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.
od: Arda Göçeroğlu, i dr.
Izdano: (2016-01-01)

Predictors of renal outcome in ANCA-assosiated glomerulonephritis
od: Ljubičić Bojana, i dr.
Izdano: (2021-01-01)

Atrial Fibrillation Due to Oral Methylprednisolone in a Patient with Membranoproliferative Glomerulonephritis
od: Ayhan Dogukan, i dr.
Izdano: (2008-01-01)

Should We Still Use Therapeutic Plasma Exchange for Rapidly Progressive Glomerulonephritis in ANCA Associated Vasculitis?
od: Andre A. Kaplan, i dr.
Izdano: (2022-07-01)

Anca-associated crescentic glomerulonephritis in a child with isolated renal involvement
od: Mehtap Ezel Çelakıl, i dr.
Izdano: (2018-09-01)

Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
od: Florian Garo, i dr.
Izdano: (2022-04-01)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
od: Wei Lin, i dr.
Izdano: (2021-03-01)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
od: Tariq Javed, i dr.
Izdano: (2012-01-01)

Pauci-immune ANCA associated glomerulonephritis. Clinical case
od: Leonid I. Dvoretsky, i dr.
Izdano: (2023-02-01)

ANCA-Negative Pauci-Immune Glomerulonephritis: A Review
od: Cristián Juanet, i dr.
Izdano: (2024-10-01)

What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?
od: Xiang Xiao, i dr.
Izdano: (2022-12-01)

Predictors of renal involvement in ANCA associated vasculitis
od: Kronbichler, A, i dr.
Izdano: (2018)

Plasma exchange and glucocorticoids in severe anca-associated vasculitis
od: Walsh, M, i dr.
Izdano: (2020)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
od: Samy Hakroush, i dr.
Izdano: (2021-10-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
od: T. V. Beketova, i dr.
Izdano: (2016-12-01)

Necrotizing ANCA-Positive Glomerulonephritis Secondary to Culture-Negative Endocarditis
od: Sophie Van Haare Heijmeijer, i dr.
Izdano: (2015-01-01)

ANCA-Negative Pauci-Immune Glomerulonephritis Associated with Bartonella Endocarditis
od: Camille Ng, i dr.
Izdano: (2024-01-01)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
od: Mukhtyar, C, i dr.
Izdano: (2007)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
od: Jones, R, i dr.
Izdano: (2010)

Bartonella Endocarditis Mimicking Crescentic Glomerulonephritis with PR3-ANCA Positivity
od: Joseph Vercellone, i dr.
Izdano: (2018-01-01)

Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study
od: Sanjeevan Sriskandarajah, i dr.
Izdano: (2017-01-01)

Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach
od: Andreas Kronbichler, i dr.
Izdano: (2024-07-01)

Outcome in Elderly Patients with Anca – Associated Glomerulonephritis Managed with Immunosuppressive Treatment
od: Karlo Kurtov, i dr.
Izdano: (2021-01-01)

Podocytes and Proteinuria in ANCA-Associated Glomerulonephritis: A Case-Control Study
od: Emma E. van Daalen, i dr.
Izdano: (2019-06-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
od: Désirée Tampe, i dr.
Izdano: (2021-09-01)

C3 glomerulonephritis associated with ANCA positivity: a case report
od: Ling Li, i dr.
Izdano: (2021-04-01)

Cardiovascular outcomes in ANCA associated vasculitis
od: Mukhtyar, C, i dr.
Izdano: (2008)

Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis
od: Ramy M. Hanna, i dr.
Izdano: (2018-08-01)

SP0133 ANCA and their environment
od: Luqmani, R
Izdano: (2017)

Diagnosis and management of ANCA associated vasculitis.
od: Berden, A, i dr.
Izdano: (2012)

Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort study
od: Tomohisa Uchida, i dr.
Izdano: (2023-02-01)

ANCA-negative idiopathic pulmonary fibrosis developed into ANCA-positive rapidly progressive glomerulonephritis after 12 years follow up
od: Chi-Yung Yeung, i dr.
Izdano: (2017-01-01)

ANCA-negative idiopathic pulmonary fibrosis developed into ANCA-positive rapidly progressive glomerulonephritis after 12 years follow up
od: Chi-Yung Yeung, i dr.
Izdano: (2017-01-01)

Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis
od: Jonas Engesser, i dr.
Izdano: (2024-09-01)

Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies
od: Adél Molnár, i dr.
Izdano: (2022-06-01)

Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients
od: Pierre Jourdain, i dr.
Izdano: (2021-04-01)

A multi-centre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (Cycazarem).
od: Luqmani, R, i dr.
Izdano: (1999)

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
od: Jones, R, i dr.
Izdano: (2009)

The prognostic value of BVAS and VDI in ANCA-AAV
od: Suppiah, R, i dr.
Izdano: (2011)

Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
od: Sung-Eun Choi, i dr.
Izdano: (2023-09-01)